BlackRock Health Sciences Term Trust (BMEZ) is an CEF managed by BlackRock / iShares. Its largest position is BLACKROCK LIQUIDITY FUNDS T-FU (TSTXX), representing 4.81% of fund assets.
BlackRock Health Sciences Term Trust Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BMEZ
- Type:
- CEF
- Manager:
- BlackRock / iShares
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
BLACKROCK LIQUIDITY FUNDS T-FU
|
4.81% | $48,671,381.57 | 48,671,382 |
|
-
JOHNSON & JOHNSON
|
3.52% | $35,599,997.16 | 145,639 |
|
-
Merck & Co., Inc.
|
3.12% | $31,562,652.52 | 262,388 |
|
-
GILEAD SCIENCES, INC.
|
2.96% | $29,929,010.65 | 214,745 |
|
-
Moderna, Inc.
|
2.76% | $27,930,551.20 | 549,814 |
|
-
BIOGEN INC.
|
2.49% | $25,205,491.71 | 137,487 |
|
-
PSIQUANTUM CORP
|
2.34% | $23,650,008.45 | 571,947 |
|
-
Edwards Lifesciences Corp
|
2.20% | $22,252,550.32 | 277,879 |
|
-
Guardant Health, Inc.
|
2.02% | $20,445,914.76 | 221,348 |
|
-
ROCHE HOLDING AG
|
1.69% | $17,096,652.61 | 42,839 |
|
-
Natera, Inc.
|
1.64% | $16,571,571.38 | 82,862 |
|
-
NOVARTIS AG
|
1.58% | $16,024,346.10 | 104,397 |
|
-
AMGEN INC
|
1.57% | $15,932,471.70 | 45,282 |
|
-
GENMAB A/S
|
1.55% | $15,663,461.69 | 58,159 |
|
-
PFIZER INC
|
1.49% | $15,129,110.88 | 538,786 |
|
-
LONZA GROUP AG
|
1.47% | $14,920,433.77 | 23,258 |
|
-
GSK plc
|
1.42% | $14,372,267.16 | 521,765 |
|
-
ILLUMINA, INC.
|
1.42% | $14,339,821.88 | 116,338 |
|
-
UCB SA
|
1.32% | $13,343,531.19 | 44,287 |
|
-
RENAGADE THERAPEUTICS A 2
|
1.29% | $13,049,057.84 | 3,584,906 |
|
-
AbbVie Inc.
|
1.28% | $13,002,422.16 | 59,784 |
|
-
AGILENT TECHNOLOGIES, INC.
|
1.27% | $12,830,272.68 | 112,566 |
|
-
SARTORIUS AG
|
1.17% | $11,817,486.81 | 47,229 |
|
-
ASTRAZENECA PLC
|
1.13% | $11,412,924.18 | 57,869 |
|
-
ADARx Pharmaceuticals, Inc.
|
1.11% | $11,282,164.47 | 860,577 |
|
-
BLACKROCK FUNDS III
|
1.10% | $11,106,155.22 | 11,103,934 |
|
-
DEXCOM INC
|
1.07% | $10,880,665.20 | 173,259 |
|
-
INTUITIVE SURGICAL INC
|
1.07% | $10,866,917.27 | 23,573 |
|
-
BRISTOL MYERS SQUIBB CO
|
1.07% | $10,784,722.35 | 177,819 |
|
-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
|
1.04% | $10,502,317.50 | 60,883 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.04% | $10,496,516.24 | 79,676 |
|
-
HOLOGIC INC.
|
1.02% | $10,370,721.23 | 137,197 |
|
-
BridgeBio Pharma, Inc.
|
1.00% | $10,157,505.58 | 136,783 |
|
-
DANAHER CORP /DE/
|
1.00% | $10,147,202.40 | 53,519 |
|
-
Medtronic plc
|
0.99% | $9,988,145.50 | 115,270 |
|
-
Immunocore Holdings plc
|
0.96% | $9,705,285.00 | 321,900 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.96% | $9,692,980.44 | 111,452 |
|
-
BOSTON SCIENTIFIC CORP
|
0.96% | $9,688,035.25 | 154,391 |
|
-
EISAI CO LTD.
|
0.94% | $9,545,445.15 | 304,900 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
0.92% | $9,332,686.00 | 20,900 |
|
-
LARONDE INC
|
0.92% | $9,313,727.64 | 482,077 |
|
-
EXELIXIS, INC.
|
0.89% | $9,014,448.64 | 210,176 |
|
-
BIO-TECHNE Corp
|
0.88% | $8,862,982.44 | 169,594 |
|
-
ARGENX SE
|
0.86% | $8,714,073.25 | 11,933 |
|
-
TERNS PHARMACEUTICALS INC
|
0.81% | $8,191,159.12 | 155,371 |
|
-
NUMAB THERAPEUTICS AG
|
0.80% | $8,107,360.49 | 1,139,305 |
|
-
IQVIA HOLDINGS INC.
|
0.79% | $7,972,233.38 | 46,747 |
|
-
KARTOS THERAPEUTICS INC
|
0.75% | $7,575,887.44 | 1,333,783 |
|
-
GENESIS THERAPEUTICS INC
|
0.74% | $7,496,667.82 | 1,370,506 |
|
-
Protagonist Therapeutics, Inc
|
0.72% | $7,257,317.00 | 68,855 |
Advertisement (320x50)